Directing the Affinity of Monoclonal Antibodies
The Antibiotic Resistance Reservoir
Match-Making Peptides with Small Molecules
Breakthrough Discovery in Diabetes
Illuminating the Life of GPCRs
Shining a Light on Psychiatric Disorders
Towards Fast Discovery of New Vaccines
Opportunities for Pan-Spectrum Drugs against Herpes
Breathing Space: Biomarkers in Pulmonary Hypertension
GPCR FlAsH-Walk Mapping: A Leap into the Future
Predicting the Unpredictable

A promising projects portfolio

As of today, CQDM has 50 outstanding research projects for a total of $ 40 M invested. These projects are carried out by a network of 610 researchers, including 100 graduate and post-graduate students, from 68 research institutions (38 public and 30 private) in Quebec, Canada and internationally. These projects cut across 100 mentors from CQDM’s pharmaceutical companies members.

completed projects